메뉴 건너뛰기




Volumn 2, Issue 4, 1996, Pages 211-224

Purine nucleoside analogues: Fludarabine, pentostatin, and cladribine: Part 2: Pentostatin

Author keywords

Cladribine; Fludarabine; Pentostatin; Purine nucleoside analogues

Indexed keywords


EID: 0141848867     PISSN: 10781552     EISSN: 1477092X     Source Type: Journal    
DOI: 10.1177/107815529600200403     Document Type: Review
Times cited : (4)

References (75)
  • 1
    • 0016177627 scopus 로고
    • A novel adenosine and Ara-A inhibitor, (R)-3(2-deoxy-β-D-erythopentofuranosyl)-3,6,7,8, tetra-hydro-imidazole (4-5d)(1-3)diazepin8-ol
    • Woo PWK, Dion HW, Lange SM,et al.A novel adenosine and Ara-A inhibitor, (R)-3(2-deoxy-β-D-erythopentofuranosyl)-3,6,7,8, tetra-hydro-imidazole (4-5d)(1-3)diazepin8-ol. J Heterocycl Chem. 1974; 11:641-643.
    • (1974) J Heterocycl Chem. , vol.11 , pp. 641-643
    • Woo, P.W.K.1    Dion, H.W.2    Lange, S.M.3
  • 2
    • 0022382997 scopus 로고
    • Study on the inhibition of adenosine deaminase
    • Montgomery JH, Thomas HJ, Zell EL,et al.Study on the inhibition of adenosine deaminase. J Med Chem. 1985;28:1751-1753.
    • (1985) J Med Chem. , vol.28 , pp. 1751-1753
    • Montgomery, J.H.1    Thomas, H.J.2    Zell, E.L.3
  • 3
    • 0021958568 scopus 로고
    • Spontaneous epimerization of S-deoxycoformycin and interaction of R-deoxycoformycin, S-deoxycoformycin, and 8-ketodeoxycoformycin with adenosine deaminase
    • Schramm VL, Baker DC Spontaneous epimerization of S-deoxycoformycin and interaction of R-deoxycoformycin, S-deoxycoformycin, and 8-ketodeoxycoformycin with adenosine deaminase. Biocbemistry. 1985;24:6641-6649.
    • (1985) Biocbemistry , vol.24 , pp. 6641-6649
    • Schramm, V.L.1    Baker, D.C.2
  • 4
    • 0025742995 scopus 로고
    • Transport of 2'-deoxycoformycin in human leukemia and lymphoma cells
    • Willey JS, Smith CL, Jameson GP Transport of 2'-deoxycoformycin in human leukemia and lymphoma cells. Biochem Pharmacol. 1991;42:708-710.
    • (1991) Biochem Pharmacol. , vol.42 , pp. 708-710
    • Willey, J.S.1    Smith, C.L.2    Jameson, G.P.3
  • 5
    • 0027097544 scopus 로고
    • Pentostatin: Future directions
    • Klohs WD, Kraker AJ Pentostatin: future directions. Pharm Rev. 1992;44:459-477.
    • (1992) Pharm Rev , vol.44 , pp. 459-477
    • Klohs, W.D.1    Kraker, A.J.2
  • 6
    • 0016774329 scopus 로고
    • The effect of external deoxynucleosides on deoxyribonucleoside triphosphate concentration in human lymphocytes
    • Tattersal MHN, Ganeshaguru K., Hoffbrand AV The effect of external deoxynucleosides on deoxyribonucleoside triphosphate concentration in human lymphocytes. Biocbem PbarinacoL 1975;24:1495-1498.
    • (1975) Biocbem PbarinacoL , vol.24 , pp. 1495-1498
    • Tattersal, M.H.N.1    Ganeshaguru, K.2    Hoffbrand, A.V.3
  • 7
    • 0018103017 scopus 로고
    • Deoxyadenosine metabolism and cytotoxicity in cultured mouse T lymphoma cells: A model for immunodeficiency disease
    • Ullman B., Gudas LJ, Cohen A.,et al.Deoxyadenosine metabolism and cytotoxicity in cultured mouse T lymphoma cells: a model for immunodeficiency disease. Cell. 1978; 14:365-375.
    • (1978) Cell. , vol.14 , pp. 365-375
    • Ullman, B.1    Gudas, L.J.2    Cohen, A.3
  • 8
    • 0024271195 scopus 로고
    • Clinical response to deoxycoformycin in chronic lymphoid neoplasms and biochemical changes in circulating malignant cells in vivo
    • Ho AD, Ganeshaguru K., Knauf WU,et al.Clinical response to deoxycoformycin in chronic lymphoid neoplasms and biochemical changes in circulating malignant cells in vivo. Blood. 1988;72:1884-1890.
    • (1988) Blood. , vol.72 , pp. 1884-1890
    • Ho, A.D.1    Ganeshaguru, K.2    Knauf, W.U.3
  • 9
    • 0020369638 scopus 로고
    • Role of DNA breaks and ADP-ribosyl transferase activity in eukaryotic differentiation demonstrated in human lymphocytes
    • Johnstone AP, Williams GT Role of DNA breaks and ADP-ribosyl transferase activity in eukaryotic differentiation demonstrated in human lymphocytes. Nature. 1982;300:368-370.
    • (1982) Nature , vol.300 , pp. 368-370
    • Johnstone, A.P.1    Williams, G.T.2
  • 10
    • 0021050706 scopus 로고
    • Purine and pyrimidine metabolism in human T lymphocytes. Regulation of deoxyribonucleotide metabolism
    • Cohen A., Barankiewicz J., Lederman HM,et al.Purine and pyrimidine metabolism in human T lymphocytes. Regulation of deoxyribonucleotide metabolism. J Biol Cbem. 1983;258:12334-12340.
    • (1983) J Biol Cbem , vol.258 , pp. 12334-12340
    • Cohen, A.1    Barankiewicz, J.2    Lederman, H.M.3
  • 11
    • 0026783019 scopus 로고
    • Induction of apoptosis in CD4+ prolymphocytic leukemia by deoxyadenosine and 2'-deoxycoformycin
    • Johnston JB, Lee K., Verburb L.,et al.Induction of apoptosis in CD4+ prolymphocytic leukemia by deoxyadenosine and 2'-deoxycoformycin. Leuk Res. 1992;16:781-788.
    • (1992) Leuk Res , vol.16 , pp. 781-788
    • Johnston, J.B.1    Lee, K.2    Verburb, L.3
  • 12
    • 0019521591 scopus 로고
    • Clinical pharmacology of 2-deoxycoformycin
    • Major PP, Agarwal RP, Kufe DW Clinical pharmacology of 2-deoxycoformycin. Blood. 1981a;58:91-96.
    • (1981) Blood. , vol.58 , pp. 91-96
    • Major, P.P.1    Agarwal, R.P.2    Kufe, D.W.3
  • 13
  • 14
    • 0019835982 scopus 로고
    • Levels of 2-deoxycoformycin and deoxyadenosine in patients with acute lymphoblastic leukemia
    • Venner PM, Glazer RI, Blatt J.,et al.Levels of 2-deoxycoformycin and deoxyadenosine in patients with acute lymphoblastic leukemia. Cancer Res. 1981;41:4508-4511.
    • (1981) Cancer Res. , vol.41 , pp. 4508-4511
    • Venner, P.M.1    Glazer, R.I.2    Blatt, J.3
  • 15
    • 0027422366 scopus 로고
    • Pentostatin: A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in lymphoproliferative disorders
    • Brogden RN, Sorkin EM Pentostatin: a review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in lymphoproliferative disorders. Drugs. 1993;46:652- 677.
    • (1993) Drugs. , vol.46 , pp. 652-677
    • Brogden, R.N.1    Sorkin, E.M.2
  • 17
    • 0019127565 scopus 로고
    • The clinical pharmacology of the adenosine deaminase inhibitor 2'-deoxycoformycin
    • Smyth JF, Paine RM, Jackman AL,et al.The clinical pharmacology of the adenosine deaminase inhibitor 2'-deoxycoformycin. Cancer Chemother Pharmacol. 1980;5:93-101.
    • (1980) Cancer Chemother Pharmacol. , vol.5 , pp. 93-101
    • Smyth, J.F.1    Paine, R.M.2    Jackman, A.L.3
  • 18
    • 0019512909 scopus 로고
    • The biochemical and clinical consequences of pentostatin in refractory lymphoproliferative malignancy
    • Grever MR, Slaw Mfe, Jacob WF,et al.The biochemical and clinical consequences of pentostatin in refractory lymphoproliferative malignancy. Blood. 1981;57:406-417.
    • (1981) Blood. , vol.57 , pp. 406-417
    • Grever, M.R.1    Slaw, M.F.E.2    Jacob, W.F.3
  • 19
    • 0019467252 scopus 로고
    • Phase 1 study of 2'-deoxycoformycin in acute lymphoblastic leukemias
    • 3435-3346
    • Poplack DG, Sallen SE, Rever G.,et al.Phase 1 study of 2'-deoxycoformycin in acute lymphoblastic leukemias. Cancer Res. 1981;41:3435-3346.
    • (1981) Cancer Res. , vol.41
    • Poplack, D.G.1    Sallen, S.E.2    Rever, G.3
  • 20
    • 0019521591 scopus 로고
    • Clinical pharmacology of deoxycoformycin
    • Major PP, Agarwal RP, Kufe DW Clinical pharmacology of deoxycoformycin. Blood. 1981;58:91-96.
    • (1981) Blood. , vol.58 , pp. 91-96
    • Major, P.P.1    Agarwal, R.P.2    Kufe, D.W.3
  • 21
    • 0026875687 scopus 로고
    • Phase I study of YK-176 (2'-deoxycoformycin) in patients with adult T-cell leukemia-lymphoma. The DCF Study Group
    • Tobinai K., Shimoyama M., Inoue S.,et al.Phase I study of YK-176 (2'-deoxycoformycin) in patients with adult T-cell leukemia-lymphoma. The DCF Study Group. Jpn J Clin Oncol. 1992;22:164-171.
    • (1992) Jpn J Clin Oncol. , vol.22 , pp. 164-171
    • Tobinai, K.1    Shimoyama, M.2    Inoue, S.3
  • 22
    • 0022272745 scopus 로고
    • Deoxycoformycin in the treatment of leukemias and lymphomas
    • Smyth JF, Prentice HG, Proctor S.,et al.Deoxycoformycin in the treatment of leukemias and lymphomas. Ann N YAcad Sci. 1985;451:123-128.
    • (1985) Ann N YAcad Sci. , vol.451 , pp. 123-128
    • Smyth, J.F.1    Prentice, H.G.2    Proctor, S.3
  • 23
    • 0021933387 scopus 로고
    • Low dose deoxycoformycin in lymphoid malignancy
    • Grever MR, Leiby JM, Kraut EH,et al.Low dose deoxycoformycin in lymphoid malignancy. J Clin Oncol. 1985;3:1196-1201.
    • (1985) J Clin Oncol. , vol.3 , pp. 1196-1201
    • Grever, M.R.1    Leiby, J.M.2    Kraut, E.H.3
  • 24
    • 0024551346 scopus 로고
    • Pentostatin in chronic lymphocytic leukemia: A phase 2 trial of the Cancer and Leukemia Group B
    • Dillman RO, Mick R., McIntyre OR Pentostatin in chronic lymphocytic leukemia: a phase 2 trial of the Cancer and Leukemia Group B. J Clin Oncol. 1989; 7:433- 438.
    • (1989) J Clin Oncol. , vol.7
    • Dillman, R.O.1    Mick, R.2    McIntyre, O.R.3
  • 25
    • 0025045158 scopus 로고
    • Pentostatin in refractory chronic lymphocytic leukemia: A phase 2 trial by the European Organization for Research and Treatment of Cancer
    • Ho AD, Thaler J., Stryckmans P.,et al.Pentostatin in refractory chronic lymphocytic leukemia: a phase 2 trial by the European Organization for Research and Treatment of Cancer. J Natl Cancer Inst. 1990;82: 1416-1420.
    • (1990) J Natl Cancer Inst. , vol.82 , pp. 1416-1420
    • Ho, A.D.1    Thaler, J.2    Stryckmans, P.3
  • 26
    • 0025283382 scopus 로고
    • Deoxycoformycin in the treatment of mature B-cell malignancies
    • Deardon C., Catovsky D. Deoxycoformycin in the treatment of mature B-cell malignancies. Br J Cancer. 1990;62:4-5.
    • (1990) Br J Cancer. , vol.62 , pp. 4-5
    • Deardon, C.1    Catovsky, D.2
  • 27
    • 0026573542 scopus 로고
    • Treatment of hairy cell leukemia
    • Saven A., Piro LD Treatment of hairy cell leukemia. Blood. 1992;79(5):1111-1120.
    • (1992) Blood. , vol.79 , Issue.5 , pp. 1111-1120
    • Saven, A.1    Piro, L.D.2
  • 28
    • 0023571468 scopus 로고
    • Treatment of hairy cell leukemia. The Ohio State experience with deoxycoformycin
    • Bouroncle BA, Grever MR, Kraught EH Treatment of hairy cell leukemia. The Ohio State experience with deoxycoformycin. Leukemia. 1987;4:350-354.
    • (1987) Leukemia , vol.4 , pp. 350-354
    • Bouroncle, B.A.1    Grever, M.R.2    Kraught, E.H.3
  • 29
    • 0024317929 scopus 로고
    • Response to pentostatin in hairy cell leukemia refractory to interferon-alpha
    • Ho AD, Thaiser J., Mandelli F.,et al.Response to pentostatin in hairy cell leukemia refractory to interferon-alpha. J Clin Oncol. 1989;7:1533-1538.
    • (1989) J Clin Oncol. , vol.7 , pp. 1533-1538
    • Ho, A.D.1    Thaiser, J.2    Mandelli, F.3
  • 30
    • 0024590995 scopus 로고
    • Pentostatin in the treatment of advanced hairy cell leukemia
    • Kraut EH, Bouroncle BA, Grever MR,et al.Pentostatin in the treatment of advanced hairy cell leukemia. J Clin Oncol. 1989;7:168-172.
    • (1989) J Clin Oncol. , vol.7 , pp. 168-172
    • Kraut, E.H.1    Bouroncle, B.A.2    Grever, M.R.3
  • 31
    • 0023680603 scopus 로고
    • Efficacy of 2'-deoxycoformycin in hairy cell leukemia: A study of the National Cancer Institute Canada Clinical Working Trials Group
    • Johnston JB, Eisenhauer E., Corbett WEN,et al.Efficacy of 2'-deoxycoformycin in hairy cell leukemia: a study of the National Cancer Institute Canada Clinical Working Trials Group. J Natl Cancer Inst. 1988;80:765-766.
    • (1988) J Natl Cancer Inst. , vol.80 , pp. 765-766
    • Johnston, J.B.1    Eisenhauer, E.2    Corbett, W.E.N.3
  • 32
    • 0023111435 scopus 로고
    • Remissions in hairy cell leukemia with pentostatin (2'-deoxycoformycin)
    • Spiers ASD, Moore D., Cassileth PA,et al.Remissions in hairy cell leukemia with pentostatin (2'-deoxycoformycin). N Engl J Med. 1987;316:825-831.
    • (1987) N Engl J Med. , vol.316 , pp. 825-831
    • Spiers, A.S.D.1    Moore, D.2    Cassileth, P.A.3
  • 33
    • 0025169752 scopus 로고
    • Durable complete remissions after 2'-deoxycoformycin treatment in patients with hairy cell leukemia resistant to interferon alpha
    • Blick M., Lepe-Zuniga JL, Doig R.,et al.Durable complete remissions after 2'-deoxycoformycin treatment in patients with hairy cell leukemia resistant to interferon alpha. Am J Hematol. 1990;33:205-209.
    • (1990) Am J Hematol , vol.33 , pp. 205-209
    • Blick, M.1    Lepe-Zuniga, J.L.2    Doig, R.3
  • 34
    • 0025980309 scopus 로고
    • Pentostatin induces durable remissions in hairy cell leukemia
    • Cassileth PA, Cheuvant B., Spiers ASD,et al.Pentostatin induces durable remissions in hairy cell leukemia. J Clin Oncol. 1991;9:243-246.
    • (1991) J Clin Oncol. , vol.9 , pp. 243-246
    • Cassileth, P.A.1    Cheuvant, B.2    Spiers, A.S.D.3
  • 35
    • 0028929938 scopus 로고
    • Randomized comparison of pentostatin vs interferon-a 2a in previously untreated patients with hairy cell leukemia
    • Grever M., Kopecky K., Foucar KM,et al.Randomized comparison of pentostatin vs interferon-a 2a in previously untreated patients with hairy cell leukemia. J Clin Oncol. 1995;13:974-982.
    • (1995) J Clin Oncol. , vol.13 , pp. 974-982
    • Grever, M.1    Kopecky, K.2    Foucar, K.M.3
  • 36
    • 0025236436 scopus 로고
    • Treatment of hairy cell leukemia with alternating cycles of pentostatin and recombinant leukocyte A interferon: Results of a phase II study
    • Martin A., Nerenstone S., Urba WJ,et al.Treatment of hairy cell leukemia with alternating cycles of pentostatin and recombinant leukocyte A interferon: results of a phase II study. J Clin Oncol. 1990;8:721-730.
    • (1990) J Clin Oncol. , vol.8 , pp. 721-730
    • Martin, A.1    Nerenstone, S.2    Urba, W.J.3
  • 37
    • 0026588745 scopus 로고
    • Sequential administration of recombinant interferon alpha and deoxycoformycin in the treatment of hairy cell leukemia
    • Haberman TM, Anderson JW, Cassileth PA,et al.Sequential administration of recombinant interferon alpha and deoxycoformycin in the treatment of hairy cell leukemia. Br J Haematol. 1992;80:466- 471.
    • (1992) Br J Haematol , vol.80
    • Haberman, T.M.1    Anderson, J.W.2    Cassileth, P.A.3
  • 38
    • 0029869521 scopus 로고    scopus 로고
    • Pentostatin (2'-deoxycorformycin, dCf) in patients with low-grade (B-T-cell) and intermediate and high grade (T-cell) malignant lymphomas a phase II study of the EORTC Early Clinical Trials Group
    • Monfardini S., Sorio R., Cavalli F.,et al.Pentostatin (2'-deoxycorformycin, dCf) in patients with low-grade (B-T-cell) and intermediate and high grade (T-cell) malignant lymphomas a phase II study of the EORTC Early Clinical Trials Group. Oncology. 1996; 53:163-168.
    • (1996) Oncology , vol.53 , pp. 163-168
    • Monfardini, S.1    Sorio, R.2    Cavalli, F.3
  • 39
    • 0025308006 scopus 로고
    • 2'deoxycoformycin (pentostatin) for refractory non-Hodgkin's lymphoma: A CALGB phase II study
    • Duggan DA, Anderson JR, Dillman R.,et al.2'deoxycoformycin (pentostatin) for refractory non-Hodgkin's lymphoma: a CALGB phase II study. Med Pediatr Oncol. 1990;18:203-209.
    • (1990) Med Pediatr Oncol. , vol.18 , pp. 203-209
    • Duggan, D.A.1    Anderson, J.R.2    Dillman, R.3
  • 40
    • 0026087131 scopus 로고
    • Phase II trial of pentostatin in refractory lymphomas and cutaneous T-cell disease
    • Cummings FJ, Kim K., Neiman RS,et al.Phase II trial of pentostatin in refractory lymphomas and cutaneous T-cell disease. J Clin Oncol. 1991;9:565-571.
    • (1991) J Clin Oncol. , vol.9 , pp. 565-571
    • Cummings, F.J.1    Kim, K.2    Neiman, R.S.3
  • 41
    • 0028151443 scopus 로고
    • The role of pentostatin in the treatment of T-cell malignancies: Analysis of response rate in 145 patients according to disease subtype
    • Mercieca J., Matutes E., Deardon C., MacLennan, Catovsky D. The role of pentostatin in the treatment of T-cell malignancies: analysis of response rate in 145 patients according to disease subtype. J Clin Oncol. 1994; 12:2588-2593.
    • (1994) J Clin Oncol. , vol.12 , pp. 2588-2593
    • Mercieca, J.1    Matutes, E.2    Deardon, C.3    MacLennan Catovsky, D.4
  • 42
    • 0020670025 scopus 로고
    • An investigation of 2'-deoxycoformycin in the treatment of cutaneous T-cell lymphoma
    • Grever MR, Bisaccia E., Scarborough DA,et al.An investigation of 2'-deoxycoformycin in the treatment of cutaneous T-cell lymphoma. Blood. 1983; 61:279-282.
    • (1983) Blood. , vol.61 , pp. 279-282
    • Grever, M.R.1    Bisaccia, E.2    Scarborough, D.A.3
  • 43
  • 44
    • 0027076455 scopus 로고
    • Phase II study of pentostatin and intermittent high-dose recombinant interferon alfa 2a in advanced mycosis fungoides/Sezary syndrome
    • Foss FM, Ihde DC, Breneman DL,et al.Phase II study of pentostatin and intermittent high-dose recombinant interferon alfa 2a in advanced mycosis fungoides/Sezary syndrome. J Clin Oncol. 1992;10: 1907-1913.
    • (1992) J Clin Oncol. , vol.10 , pp. 1907-1913
    • Foss, F.M.1    Ihde, D.C.2    Breneman, D.L.3
  • 45
    • 0025729043 scopus 로고
    • Phase II study of 2'-deoxycoformycin in patients with renal cell carcinoma. A National Cancer Institute of Canada Clinical Trials Group study
    • Venner P., Eisenhauer EA, Wierzbicki R.,et al.Phase II study of 2'-deoxycoformycin in patients with renal cell carcinoma. A National Cancer Institute of Canada Clinical Trials Group study. Invest New Drugs. 1991;9:273-275.
    • (1991) Invest New Drugs. , vol.9 , pp. 273-275
    • Venner, P.1    Eisenhauer, E.A.2    Wierzbicki, R.3
  • 46
    • 0027096559 scopus 로고
    • A phase II investigation of pentostatin in metastatic malignant melanoma
    • Grever MR, Brager P., Metz E. A phase II investigation of pentostatin in metastatic malignant melanoma. Invest New Drugs. 1992;10:345-346.
    • (1992) Invest New Drugs. , vol.10 , pp. 345-346
    • Grever, M.R.1    Brager, P.2    Metz, E.3
  • 47
    • 0025689969 scopus 로고
    • Phase II investigation of pentostatin in multiple myeloma: A Southwest Oncology Group study
    • Grever MR, Crowley J., Salmon S.,et al.Phase II investigation of pentostatin in multiple myeloma: a Southwest Oncology Group study. J Natl Cancer Inst. 1990;22:1778-1779.
    • (1990) J Natl Cancer Inst. , vol.22 , pp. 1778-1779
    • Grever, M.R.1    Crowley, J.2    Salmon, S.3
  • 48
    • 0026454996 scopus 로고
    • Lack of significant activity of 2'-deoxycoformycin alone or in combination with adenine arabinoside in relapsed childhood acute llymphoblastic leukemia: A randomized phase II trial from the Childrens Cancer Study Group
    • Miser JS, Roloff J., Blatt J.,et al.Lack of significant activity of 2'-deoxycoformycin alone or in combination with adenine arabinoside in relapsed childhood acute llymphoblastic leukemia: a randomized phase II trial from the Childrens Cancer Study Group. Am J Clin Oncol. 1992;15:490-493.
    • (1992) Am J Clin Oncol. , vol.15 , pp. 490-493
    • Miser, J.S.1    Roloff, J.2    Blatt, J.3
  • 50
    • 79957811427 scopus 로고    scopus 로고
    • Infectious and immunosuppressive complications of purine analogue therapy
    • Cheson BD. Infectious and immunosuppressive complications of purine analogue therapy.
    • Cheson, B.D.1
  • 51
    • 0022508693 scopus 로고
    • Association of severe and fatal infections and treatment with pentostatin
    • O'Dwyer PJ, Spiers Asd, Maroni S.,et al.Association of severe and fatal infections and treatment with pentostatin. Cancer Treat Rep. 1986;70:117-120.
    • (1986) Cancer Treat Rep. , vol.70 , pp. 117-120
    • O'Dwyer, P.J.1    Spiers, A.S.D.2    Maroni, S.3
  • 52
    • 0023493235 scopus 로고
    • The role of pentostatin (2'-deoxycoformycin) in the management of lymphoproliferative malignancies
    • Speirs ASD. The role of pentostatin (2'-deoxycoformycin) in the management of lymphoproliferative malignancies. Blood Rev. 1987;1:106-110.
    • (1987) Blood Rev. , vol.1 , pp. 106-110
    • Speirs, A.S.D.1
  • 53
    • 0017102172 scopus 로고
    • Effects of adenosine analogs on rat cerebral cortical neurons
    • Phillis JW, Edstrom JP Effects of adenosine analogs on rat cerebral cortical neurons. Life Sci. 1976; 19: 1041-1054.
    • (1976) Life Sci. , vol.19 , pp. 1041-1054
    • Phillis, J.W.1    Edstrom, J.P.2
  • 56
    • 0019521591 scopus 로고
    • Clinical pharmacology of deoxycoformycin
    • Major PP, Agarwal RP, Kufe DW Clinical pharmacology of deoxycoformycin. Blood. 1981;58:91-96.
    • (1981) Blood. , vol.58 , pp. 91-96
    • Major, P.P.1    Agarwal, R.P.2    Kufe, D.W.3
  • 58
    • 24044431915 scopus 로고
    • A randomized comparison of deoxycoformycin (DCF) versus alpha-2a interferon (IFN) in previously untreated patients with hairy cell leukemia (HCL): An NCI sponsored intergroup study (SWOG, ECOG, CALGB, NCIC, CTG)
    • Grever M., Kopecky K., Head D.,et al.A randomized comparison of deoxycoformycin (DCF) versus alpha-2a interferon (IFN) in previously untreated patients with hairy cell leukemia (HCL): an NCI sponsored intergroup study (SWOG, ECOG, CALGB, NCIC, CTG). Proc Am Soc Clin Oncol. 1992;11:868.
    • (1992) Proc Am Soc Clin Oncol. , vol.11 , pp. 868
    • Grever, M.1    Kopecky, K.2    Head, D.3
  • 59
    • 0023945047 scopus 로고
    • 2'-deoxycoformycin (pentostatin) for lymphoid malignancies: Rational development of an active new drug
    • O'Dwyer PJ, Wagner B., Leyland-Jones B.,et al.2'-deoxycoformycin (pentostatin) for lymphoid malignancies: rational development of an active new drug. Ann Intern Med. 1988;108:733-743.
    • (1988) Ann Intern Med. , vol.108 , pp. 733-743
    • O'Dwyer, P.J.1    Wagner, B.2    Leyland-Jones, B.3
  • 60
    • 0019731629 scopus 로고
    • Therapeutic selectivity of and prediction of response 2'-deoxycoformycin in acute leukemia
    • Prentice HG, Russell NH, Lee L.,et al.Therapeutic selectivity of and prediction of response 2'-deoxycoformycin in acute leukemia. Lancet. 1981;2: 1250-1254.
    • (1981) Lancet , vol.2 , pp. 1250-1254
    • Prentice, H.G.1    Russell, N.H.2    Lee, L.3
  • 61
    • 0020472804 scopus 로고
    • Treatment of lymphoid malignancies with 2-deoxycoformycin: A pilot study
    • Karnofsky JR, Baron JM, Roth DG,et al.Treatment of lymphoid malignancies with 2-deoxycoformycin: a pilot study. Am J Clin Oncol. 1982;5:179-183.
    • (1982) Am J Clin Oncol. , vol.5 , pp. 179-183
    • Karnofsky, J.R.1    Baron, J.M.2    Roth, D.G.3
  • 62
    • 0019512909 scopus 로고
    • The biochemical and clinical consequences of 2'-deoxycoformycin in refractory lymphoproliferative malignancy
    • Grever MR, Siaw Mfe, Jacob WFet al.The biochemical and clinical consequences of 2'-deoxycoformycin in refractory lymphoproliferative malignancy. Blood. 1981;57:406-417.
    • (1981) Blood. , vol.57 , pp. 406-417
    • Grever, M.R.1    Siaw, M.F.E.2    Jacob, W.F.3
  • 63
    • 79957809502 scopus 로고    scopus 로고
    • Fatal recurrence of autoimmune hemolytic anemia following pentostatin therapy in a patient with fludarabine-associated hemolytic anemia
    • Bryd JC, Hutler AA, Weiss RB,et al.Fatal recurrence of autoimmune hemolytic anemia following pentostatin therapy in a patient with fludarabine-associated hemolytic anemia. Ann Oncol.
    • Ann Oncol.
    • Bryd, J.C.1    Hutler, A.A.2    Weiss, R.B.3
  • 64
    • 0029046557 scopus 로고
    • Hemolytic uremia syndrome due to deoxycorformycin: A report of the second case
    • Sakai C., Takagi T., Wakatsuki S., Matsuzaki O. Hemolytic uremia syndrome due to deoxycorformycin: a report of the second case. Intern Med. 1995;34:593-596.
    • (1995) Intern Med. , vol.34 , pp. 593-596
    • Sakai, C.1    Takagi, T.2    Wakatsuki, S.3    Matsuzaki, O.4
  • 65
    • 0025005559 scopus 로고
    • Vomiting associated with pentostatin and pentostatin plus interferon: Unique pattern and potential mechanisms
    • Lindley CM, Bernard SA, Robertson JD Vomiting associated with pentostatin and pentostatin plus interferon: unique pattern and potential mechanisms. J Pain Symptom Manage. 1990;5:262-264.
    • (1990) J Pain Symptom Manage , vol.5 , pp. 262-264
    • Lindley, C.M.1    Bernard, S.A.2    Robertson, J.D.3
  • 66
    • 0021933387 scopus 로고
    • Low dose deoxycoformycin in lymphoid malignancy
    • Grever MR, Leiby JM, Kraut EH,et al.Low dose deoxycoformycin in lymphoid malignancy. J Clin Oncol. 1985;3:1196-1201.
    • (1985) J Clin Oncol. , vol.3 , pp. 1196-1201
    • Grever, M.R.1    Leiby, J.M.2    Kraut, E.H.3
  • 67
    • 0025944044 scopus 로고
    • Cardiac complications observed in elderly patients following 2'deoxycoformycin therapy
    • Grem JK, King SA, Chun HG,et al.Cardiac complications observed in elderly patients following 2'deoxycoformycin therapy. Am J Hematol. 1991;38: 245-247.
    • (1991) Am J Hematol , vol.38 , pp. 245-247
    • Grem, J.K.1    King, S.A.2    Chun, H.G.3
  • 68
    • 0021241953 scopus 로고
    • Combination of 2'-deoxycoformycin and vidarabine in advanced malignancy: Clinical and biochemical observations
    • Grever MR, Malspeis L., Kraut EH,et al.Combination of 2'-deoxycoformycin and vidarabine in advanced malignancy: clinical and biochemical observations. Cancer Treat Symp. 1984;2:97-104.
    • (1984) Cancer Treat Symp. , vol.2 , pp. 97-104
    • Grever, M.R.1    Malspeis, L.2    Kraut, E.H.3
  • 69
    • 0020071883 scopus 로고
    • Modulation of 9-β-d-arabinofuranosyladenine 5'-triphosphate deoxyadenosine triphosphate in leukemic cells by 2'-deoxycoformycin during therapy with 9-β-D-arabinofuranosyladenine
    • Plunkett W., Benjamin RS, Keating MJ,et al.Modulation of 9-β-d-arabinofuranosyladenine 5'-triphosphate deoxyadenosine triphosphate in leukemic cells by 2'-deoxycoformycin during therapy with 9-β-D-arabinofuranosyladenine. Cancer Res. 1982; 42:2092-2096.
    • (1982) Cancer Res. , vol.42 , pp. 2092-2096
    • Plunkett, W.1    Benjamin, R.S.2    Keating, M.J.3
  • 70
    • 0027321623 scopus 로고
    • Pentostatin increases the acute toxicity of high dose cyclophosphamide
    • Gryn J., Gordon R., Bapat A.,et al.Pentostatin increases the acute toxicity of high dose cyclophosphamide. Bone Marrow Transplant. 1992;12:217-220.
    • (1992) Bone Marrow Transplant. , vol.12 , pp. 217-220
    • Gryn, J.1    Gordon, R.2    Bapat, A.3
  • 71
    • 0021366307 scopus 로고
    • Severe allopurinol toxicity: Description and guidelines for prevention in patients with renal insufficiency
    • Hande KR, Noone RM, Stone WJ Severe allopurinol toxicity: description and guidelines for prevention in patients with renal insufficiency. Am J Med. 1984;7G:47-56.
    • (1984) Am J Med. , vol.7 G , pp. 47-56
    • Hande, K.R.1    Noone, R.M.2    Stone, W.J.3
  • 72
    • 0026717636 scopus 로고
    • Pentostatin: An adenosine deaminase inhibitor for the treatment of hairy cell leukemia
    • Kane BJ, Kuhn JG, Roush MK Pentostatin: an adenosine deaminase inhibitor for the treatment of hairy cell leukemia. Ann Pharm. 1992;26:939-947.
    • (1992) Ann Pharm. , vol.26 , pp. 939-947
    • Kane, B.J.1    Kuhn, J.G.2    Roush, M.K.3
  • 73
    • 79957825683 scopus 로고    scopus 로고
    • Product information. Nipent. Parke Davis, Morris Plains, NJ, 1991
    • Product information. Nipent. Parke Davis, Morris Plains, NJ, 1991.
  • 74
    • 0025050686 scopus 로고
    • Chemical stability of pentostatin (NSC-218321): A cytotoxic and immunosuppressive agent
    • Al-Razzak LA, Benedetti AE, Waugh WN,et al.Chemical stability of pentostatin (NSC-218321): a cytotoxic and immunosuppressive agent. Pharmaceut Res. 1990;7:452-460.
    • (1990) Pharmaceut Res. , vol.7 , pp. 452-460
    • Al-Razzak, L.A.1    Benedetti, A.E.2    Waugh, W.N.3
  • 75
    • 79957829267 scopus 로고
    • Visual compatibility of ondansetron with chemotherapeutic agents, antibiotics, and other selected drugs during simulated Y-site injection
    • Presented at the 25th Annual ASHP Midyear Clinical Meetings and Exhibit, Las Vegas, NV, Abstract P-468R
    • Trissel LA, Fulton B., Tramonte SM Visual compatibility of ondansetron with chemotherapeutic agents, antibiotics, and other selected drugs during simulated Y-site injection. Presented at the 25th Annual ASHP Midyear Clinical Meetings and Exhibit, Las Vegas, NV, 1990. Abstract P-468R.
    • (1990)
    • Trissel, L.A.1    Fulton, B.2    Tramonte, S.M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.